Minerva medica最新文献

筛选
英文 中文
Relationship between serum CA125, TIMP-1 and SAA levels and clinicopathological characteristics and prognosis in patients with non-small cell lung cancer. 非小细胞肺癌患者血清 CA125、TIMP-1 和 SAA 水平与临床病理特征和预后的关系。
Minerva medica Pub Date : 2024-06-05 DOI: 10.23736/S0026-4806.24.09306-6
Xin Chen, Xiang He, Yuan Li, Bing Guo, Guangyu Chen
{"title":"Relationship between serum CA125, TIMP-1 and SAA levels and clinicopathological characteristics and prognosis in patients with non-small cell lung cancer.","authors":"Xin Chen, Xiang He, Yuan Li, Bing Guo, Guangyu Chen","doi":"10.23736/S0026-4806.24.09306-6","DOIUrl":"https://doi.org/10.23736/S0026-4806.24.09306-6","url":null,"abstract":"","PeriodicalId":94143,"journal":{"name":"Minerva medica","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-06-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141263678","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Non-cardiac comorbidities in heart failure: an update on diagnostic and management strategies. 心力衰竭的非心脏并发症:诊断和管理策略的最新进展。
Minerva medica Pub Date : 2024-06-01 DOI: 10.23736/S0026-4806.24.09070-0
Nandan Kodur, W H Wilson Tang
{"title":"Non-cardiac comorbidities in heart failure: an update on diagnostic and management strategies.","authors":"Nandan Kodur, W H Wilson Tang","doi":"10.23736/S0026-4806.24.09070-0","DOIUrl":"10.23736/S0026-4806.24.09070-0","url":null,"abstract":"<p><p>Managing non-cardiac comorbidities in heart failure (HF) requires a tailored approach that addresses each patient's specific conditions and needs. Regular communication and coordination among healthcare providers is crucial to providing the best possible care for these patients. Poorly controlled hypertension contributes to left ventricular remodeling and diastolic dysfunction, emphasizing the importance of optimal blood pressure control while avoiding adverse effects. Among HF patients with diabetes, SGLT2 inhibitors and mineralocorticoid receptor antagonists have shown promise in reducing HF-related morbidity and mortality. Chronic kidney disease exacerbates HF and vice versa, forming the vicious cardiorenal syndrome, so disease-modifying therapies should be maintained in HF patients with comorbid CKD, even with transient changes in kidney function. Anemia in HF patients may be multifactorial, and there is growing evidence for the benefit of intravenous iron supplementation in HF patients with iron deficiency with or without anemia. Obesity, although a risk factor for HF, paradoxically offers a better prognosis once HF is established, though developing treatment strategies may improve symptoms and cardiac performance. In HF patients with stroke and atrial fibrillation, anticoagulation therapy is recommended. Among HF patients with sleep-disordered breathing, continuous positive airway pressure may improve sleep quality. Chronic obstructive pulmonary disease often coexists with HF, and many patients can tolerate cardioselective beta-blockers. Cancer patients with comorbid HF require careful consideration of cardiotoxicity risks associated with cancer therapies. Depression is underdiagnosed in HF patients and significantly impacts prognosis. Cognitive impairment is prevalent in HF patients and impacts their self-care and overall quality of life.</p>","PeriodicalId":94143,"journal":{"name":"Minerva medica","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141428549","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Application of positive expiratory pressure therapeutic apparatus in pulmonary rehabilitation of patients with chronic obstructive pulmonary disease. 呼气正压治疗仪在慢性阻塞性肺病患者肺康复中的应用。
Minerva medica Pub Date : 2024-06-01 Epub Date: 2024-01-19 DOI: 10.23736/S0026-4806.23.09040-7
Sihui Zheng, Yanhong Wang
{"title":"Application of positive expiratory pressure therapeutic apparatus in pulmonary rehabilitation of patients with chronic obstructive pulmonary disease.","authors":"Sihui Zheng, Yanhong Wang","doi":"10.23736/S0026-4806.23.09040-7","DOIUrl":"10.23736/S0026-4806.23.09040-7","url":null,"abstract":"","PeriodicalId":94143,"journal":{"name":"Minerva medica","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139492860","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impaired endogenous fibrinolysis status: a potential prognostic predictor in ischemic stroke. 内源性纤溶状态受损:缺血性脑卒中的潜在预后预测因素。
Minerva medica Pub Date : 2024-06-01 Epub Date: 2024-05-09 DOI: 10.23736/S0026-4806.24.09133-X
Yang Chen, Ying Gue, Garry McDowell, Diana A Gorog, Gregory Y H Lip
{"title":"Impaired endogenous fibrinolysis status: a potential prognostic predictor in ischemic stroke.","authors":"Yang Chen, Ying Gue, Garry McDowell, Diana A Gorog, Gregory Y H Lip","doi":"10.23736/S0026-4806.24.09133-X","DOIUrl":"10.23736/S0026-4806.24.09133-X","url":null,"abstract":"<p><p>Stroke confers a severe global healthcare burden, hence exploring risk factors for stroke occurrence and prognosis is important for stroke prevention and post-stroke management strategies. Endogenous fibrinolysis is a spontaneous physiological protective mechanism that dissolves thrombus to maintain vascular patency. Recently, impaired endogenous fibrinolysis has been considered as a potential novel cardiovascular risk factor, but its link with ischaemic stroke in the past has been underappreciated. In this review, we summarize the latest mechanisms of endogenous fibrinolysis, review the current evidence and data on endogenous fibrinolysis in ischemic stroke. It includes the structure of thrombus in ischemic stroke patients, the effect of fibrin structure on the endogenous fibrinolytic efficiency, and the association between intravenous thrombolytic therapy and endogenous fibrinolysis in ischemic stroke. It also includes the single factors (tissue plasminogen activator, urokinase plasminogen activator, plasminogen activator inhibitor-1, thrombin activatable fibrinolysis inhibitor, complement component 3, complement component 5, alpha-2-antiplasmin, plasmin-alpha-2-antiplasmin complex, and lipoprotein[a]), and the global assessments of endogenous fibrinolysis status (thromboelastography, rotational thromboelastometry, and global thrombosis test), and their potential as predictors to identify occurrence or unfavorable functional outcomes of ischemic stroke. All of these assessments present advantages and limitations, and we suggest that the global thrombosis test may be more appropriate for detecting impaired endogenous fibrinolysis status in ischemic stroke patients.</p>","PeriodicalId":94143,"journal":{"name":"Minerva medica","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140900756","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Educational status and the risk of adverse outcomes in Asian patients with atrial fibrillation: a report from the prospective APHRS-AF Registry. 亚洲心房颤动患者的教育状况与不良后果风险:来自前瞻性 APHRS-AF 登记处的报告。
Minerva medica Pub Date : 2024-06-01 Epub Date: 2024-05-09 DOI: 10.23736/S0026-4806.24.09159-6
Tommaso Bucci, Giulio F Romiti, Bernadette Corica, Alena Shantsila, Wee-Siong Teo, Hyung-Wook Park, Wataru Shimizu, Hung-Fat Tse, Marco Proietti, Tze-Fan Chao, Gregory Y H Lip
{"title":"Educational status and the risk of adverse outcomes in Asian patients with atrial fibrillation: a report from the prospective APHRS-AF Registry.","authors":"Tommaso Bucci, Giulio F Romiti, Bernadette Corica, Alena Shantsila, Wee-Siong Teo, Hyung-Wook Park, Wataru Shimizu, Hung-Fat Tse, Marco Proietti, Tze-Fan Chao, Gregory Y H Lip","doi":"10.23736/S0026-4806.24.09159-6","DOIUrl":"10.23736/S0026-4806.24.09159-6","url":null,"abstract":"<p><strong>Background: </strong>The aim of this study was to evaluate the impact of educational status (ES) on the clinical course of Asian patients with atrial fibrillation (AF).</p><p><strong>Methods: </strong>We used data from the prospective APHRS-AF Registry. ES was classified as follows: low (primary school), medium (secondary), and high (University). The primary outcome was a composite of all-cause death, thromboembolic events, acute coronary syndrome, and heart failure. Secondary outcomes were each component of the primary outcome, cardiovascular death, and major bleeding. The one-year risk of primary and secondary outcomes was assessed through Cox-regressions. Adherence to the Atrial fibrillation Better Care (ABC) pathway was assessed.</p><p><strong>Results: </strong>Among 2697 AF patients (69±12 years, 34.8% females), 34.6% had low ES; 37.3% had medium ES; and 28.1% had high ES. Compared to patients with medium-high ES, patients with low ES were older, more often females, with a higher prevalence of cardiovascular risk factors, and a lower ABC pathway adherence (30.4% vs. 40.2%, P<0.001). On multivariable analysis, low ES was associated with a higher risk for the primary outcome (HR 1.52,95%CI 1.11-2.06) and all-cause death (HR 1.76,95%CI 1.10-2.83) than medium-high ES. A significant interaction was found for the risk of composite outcome among the different age strata, with the higher risk in the elderly (P for int=0.008), whereas the beneficial effect of the ABC pathway was irrespective of ES (P for int=0.691).</p><p><strong>Conclusions: </strong>In Asian AF patients, low ES is associated with high mortality. Efforts to improve education and include ES evaluation in the integrated care approach for AF are necessary to reduce the cardiovascular burden in these patients.</p>","PeriodicalId":94143,"journal":{"name":"Minerva medica","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140900735","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hepatitis C virus-related autoimmunity before and after viral clearance: a single center, prospective, observational study. 病毒清除前后与丙型肝炎病毒相关的自身免疫:一项单中心、前瞻性、观察性研究。
Minerva medica Pub Date : 2024-06-01 Epub Date: 2024-04-24 DOI: 10.23736/S0026-4806.24.09170-5
Gianfranco Lauletta, Sebastiano Cicco, Franco Dammacco
{"title":"Hepatitis C virus-related autoimmunity before and after viral clearance: a single center, prospective, observational study.","authors":"Gianfranco Lauletta, Sebastiano Cicco, Franco Dammacco","doi":"10.23736/S0026-4806.24.09170-5","DOIUrl":"10.23736/S0026-4806.24.09170-5","url":null,"abstract":"<p><strong>Background: </strong>Hepatitis C virus (HCV) chronic infection is frequently associated to autoimmune manifestations. The aim of this study was to prospectively evaluate the occurrence of clinical and/or laboratory features of autoimmunity in a cohort of 140 consecutive HCV chronically infected patients treated with direct-acting antiviral agents (DAAs) and followed-up for 96 weeks.</p><p><strong>Methods: </strong>All patients were screened for cryoglobulins, rheumatoid factor (RF), C3, C4, antinuclear antibody (ANA), anti-smooth muscle (ASMA), anti-liver kidney microsome type 1 (anti-LKM1), anti-mitochondrial antibodies (AMA), anti-neutrophil cytoplasmic antibodies (ANCA), and anti-liver cytosol type 1/soluble liver antigen (anti-LC1/SLA) autoantibodies before therapy and 12, 48 and 96 weeks after treatment. They were then grouped according to the expression of laboratory findings and related autoimmune diseases.</p><p><strong>Results: </strong>At baseline, autoimmune manifestations were found in 70 patients: 83% of them were cryoglobulinemic, whereas ANA, AMA, perinuclear ANCA (pANCA) and LKM/LC1 autoantibodies were found in the remaining 17%. An autoimmune disease was diagnosed in 9 cases, two of them featuring an autoimmune liver disease (AILD). At the end of follow-up, despite viral clearance and regression of vasculitis, cryoglobulins persisted in 12 patients (21%), and autoantibodies disappeared or decreased in most of cases but, with the exception of the 2 patients diagnosed as AILD, associated autoimmune diseases remained stable. In one patient with relapsing cryoglobulinemia and ANA positivity, type-1 autoimmune hepatitis was defined. Conversely, autoantibodies first appeared after viral clearance in 5 patients, of whom one was diagnosed with type-1 autoimmune hepatitis and one with pANCA+ primary sclerosing cholangitis.</p><p><strong>Conclusions: </strong>Following DAA-induced viral clearance, cryoglobulins may persist or reappear. Autoantibodies changed dynamically in step with the disappearance of a previously diagnosed or the occurrence of a new AILD. A longer follow-up will be necessary to establish the possible diagnosis of a newly onset AILD, the reactivation of cryoglobulinemic vasculitis and even its progression to non-Hodgkin lymphoma.</p>","PeriodicalId":94143,"journal":{"name":"Minerva medica","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140873661","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Triglyceride-Glucose Index, HOMA Index and metabolic syndrome in a sample of adult men. 成年男性样本中的甘油三酯-葡萄糖指数、HOMA 指数和代谢综合征。
Minerva medica Pub Date : 2024-06-01 Epub Date: 2024-05-09 DOI: 10.23736/S0026-4806.24.09155-9
Lanfranco D'Elia, Maria Masulli, Antonio Barbato, Domenico Rendina, Roberto Iacone, Ornella Russo, Pasquale Strazzullo, Ferruccio Galletti
{"title":"Triglyceride-Glucose Index, HOMA Index and metabolic syndrome in a sample of adult men.","authors":"Lanfranco D'Elia, Maria Masulli, Antonio Barbato, Domenico Rendina, Roberto Iacone, Ornella Russo, Pasquale Strazzullo, Ferruccio Galletti","doi":"10.23736/S0026-4806.24.09155-9","DOIUrl":"10.23736/S0026-4806.24.09155-9","url":null,"abstract":"<p><strong>Background: </strong>Metabolic syndrome (MetS) and its components are directly associated with cardiovascular risk. Insulin resistance (IR) is the most common pathophysiological feature of MetS. A novel index, the triglyceride-glucose index (TyG), is considered a surrogate marker of IR. Hence, we estimated the ability of TyG to predict the risk to develop MetS over a follow-up period of 8 years. In addition, we compared the predictive role of TyG and that of the HOmeostatis Model Assessment (HOMA) of IR index (a widely used tool to evaluate IR).</p><p><strong>Methods: </strong>The analysis included 440 adult men (The Olivetti Heart Study) without MetS at baseline. The optimal cut-off point of the association of continuous TyG or HOMA-IR with MetS was identified by ROC analysis.</p><p><strong>Results: </strong>During the follow-up period, 21.6% of participants developed MetS. Baseline TyG and HOMA-IR were both significantly greater in those who developed MetS than in those who did not. These results were confirmed upon adjustment for the main confounders. After stratification by the optimal cut-off point, TyG >4.78 was a significant predictor of MetS, also after adjustment for main confounders. Likewise, HOMA-IR >2.14 was associated with the risk of MetS development in multivariate models.</p><p><strong>Conclusions: </strong>The results of this prospective study indicate a significant predictive role of TyG on the risk of MetS, independently of the main confounders. They suggest that TyG may serve as a low-cost and simple non-invasive marker for cardio-metabolic risk stratification, with respect to more complex and expensive assays of IR requiring the insulin measurement.</p>","PeriodicalId":94143,"journal":{"name":"Minerva medica","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140900758","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The practical value of OBE education concept in sports training. OBE教育理念在运动训练中的应用价值。
Minerva medica Pub Date : 2024-06-01 Epub Date: 2023-11-14 DOI: 10.23736/S0026-4806.23.08894-8
Hongxiao Wang, Xiaoqi Zhang, Xiaobin Huang
{"title":"The practical value of OBE education concept in sports training.","authors":"Hongxiao Wang, Xiaoqi Zhang, Xiaobin Huang","doi":"10.23736/S0026-4806.23.08894-8","DOIUrl":"10.23736/S0026-4806.23.08894-8","url":null,"abstract":"","PeriodicalId":94143,"journal":{"name":"Minerva medica","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"92158156","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical observation of aplastic anemia complicated with hepatitis in children. 儿童再生障碍性贫血并发肝炎的临床观察。
Minerva medica Pub Date : 2024-06-01 Epub Date: 2024-01-29 DOI: 10.23736/S0026-4806.23.08992-9
Guangning Liu, Zemin Zhang, Zhenli Wang
{"title":"Clinical observation of aplastic anemia complicated with hepatitis in children.","authors":"Guangning Liu, Zemin Zhang, Zhenli Wang","doi":"10.23736/S0026-4806.23.08992-9","DOIUrl":"10.23736/S0026-4806.23.08992-9","url":null,"abstract":"","PeriodicalId":94143,"journal":{"name":"Minerva medica","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139576999","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Alcohol use disorders and liver fibrosis: an update. 酒精使用障碍与肝纤维化:最新进展。
Minerva medica Pub Date : 2024-06-01 Epub Date: 2024-05-09 DOI: 10.23736/S0026-4806.24.09203-6
Fabio Caputo, Francesco Penitenti, Barbara Bergonzoni, Lisa Lungaro, Anna Costanzini, Giacomo Caio, Roberto DE Giorgio, Maria R Ambrosio, Giorgio Zoli, Gianni Testino
{"title":"Alcohol use disorders and liver fibrosis: an update.","authors":"Fabio Caputo, Francesco Penitenti, Barbara Bergonzoni, Lisa Lungaro, Anna Costanzini, Giacomo Caio, Roberto DE Giorgio, Maria R Ambrosio, Giorgio Zoli, Gianni Testino","doi":"10.23736/S0026-4806.24.09203-6","DOIUrl":"10.23736/S0026-4806.24.09203-6","url":null,"abstract":"<p><p>Alcoholic liver disease (ALD) is currently, worldwide, the second most common cause of human fatalities every year. Alcohol use disorders (AUDs) lead to 80% of hepatotoxic deaths, and about 40% of cases of cirrhosis are alcohol-related. An acceptable daily intake (ADI) of ethanol is hard to establish and studies somewhat controversially recommend a variety of dosages of ADI, whilst others regard any intake as dangerous. Steatohepatitis should be viewed as \"the rate limiting step\": generally, it can be overcome by abstinence, although in some patients, abstinence has little effect, with the risk of fibrosis, leading in some cases to hepatocellular carcinoma (HCC). Chronic alcoholism can also cause hypercortisolism, specifically pseudo-Cushing Syndrome, whose diagnosis is challenging. If fibrosis is spotted early, patients may be enrolled in detoxification programs to achieve abstinence. Treatment drugs include silybin, metadoxine and adenosyl methionine. Nutrition and the proper use of micronutrients are important, albeit often overlooked in ALD treatment. Other drugs, with promising antifibrotic effects, are now being studied. This review deals with the clinical and pathogenetic aspects of alcohol-related liver fibrosis and suggests possible future strategies to prevent cirrhosis.</p>","PeriodicalId":94143,"journal":{"name":"Minerva medica","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140900711","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信